What does DR. VERCRUYSSE L. – DR. DE BROUWER M. do?

DR. VERCRUYSSE L. – DR. DE BROUWER M. is a general practice in Gent. Private Limited, started on 24 June 2021, 1 establishment.

What is the address of DR. VERCRUYSSE L. – DR. DE BROUWER M.?

The registered office of DR. VERCRUYSSE L. – DR. DE BROUWER M. is located at Stropstraat 147, 9000 Gent.

Is DR. VERCRUYSSE L. – DR. DE BROUWER M. still active?

Yes. According to the CBE (18 September 2026) DR. VERCRUYSSE L. – DR. DE BROUWER M. is active, legal situation “Normale toestand”, started on 24 June 2021.

Is DR. VERCRUYSSE L. – DR. DE BROUWER M. registered on Peppol?

Yes, DR. VERCRUYSSE L. – DR. DE BROUWER M. is registered on the Peppol network with ID 0208:0770301447.

What is the enterprise number of DR. VERCRUYSSE L. – DR. DE BROUWER M.?

The enterprise number of DR. VERCRUYSSE L. – DR. DE BROUWER M. is BE0770301447.

When was DR. VERCRUYSSE L. – DR. DE BROUWER M. founded?

DR. VERCRUYSSE L. – DR. DE BROUWER M. was founded on 24 June 2021.

Who are the directors of DR. VERCRUYSSE L. – DR. DE BROUWER M.?

According to the 2025 annual accounts, the directors of DR. VERCRUYSSE L. – DR. DE BROUWER M. are: Loes Vercruysse, Mathias De Brouwer.

Is DR. VERCRUYSSE L. – DR. DE BROUWER M. a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 24 June 2021; 4 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did DR. VERCRUYSSE L. – DR. DE BROUWER M. make in 2025?

DR. VERCRUYSSE L. – DR. DE BROUWER M. posted a profit after taxes of € 108,114 in financial year 2025.

What is the revenue of DR. VERCRUYSSE L. – DR. DE BROUWER M.?

As a small company, DR. VERCRUYSSE L. – DR. DE BROUWER M. is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 138,942.

DR. VERCRUYSSE L. – DR. DE BROUWER M. (Private Limited)

Dossier DR. VERCRUYSSE L. – DR. DE BROUWER M., printed on 18 September 2026 from databakkes.be/en/0770301447/dr-vercruysse-l-dr-de-brouwer-m. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. VERCRUYSSE L. – DR. DE BROUWER M. from Gent, company number BE0770301447, closed financial year 2025 with a result of € 108,114 after tax. For that financial year DR. VERCRUYSSE L. – DR. DE BROUWER M. recorded a gross margin of € 138,942 and equity of € 2,000. Compared with financial year 2024, the result moved from € 110,196 to € 108,114. The company is profitable. The buffer shrank hard: equity is 99 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on February 12, 2026.

What it is worth Shrank hard

€ 2,000

▼ 99% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 108,114

▼ 2% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 64,570

▼ 64% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 382,900 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 6,721

▼ 73% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 4,762

▲ 42% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 2,850

▼ 49% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 160,018 Gross margin 2022: € 160,018 First fiscal year in the series	€ 68,402 Gross margin 2023: € 68,402 ▼ 57% vs 2022 (€ 160,018) Unfavourable step	€ 151,215 Gross margin 2024: € 151,215 ▲ 121% vs 2023 (€ 68,402) Favourable step	€ 138,942 Gross margin 2025: € 138,942 ▼ 8% vs 2024 (€ 151,215) Unfavourable step	▼ 8%
Profit after taxes	€ 120,193 Profit after taxes 2022: € 120,193 First fiscal year in the series	€ 47,657 Profit after taxes 2023: € 47,657 ▼ 60% vs 2022 (€ 120,193) Unfavourable step	€ 110,196 Profit after taxes 2024: € 110,196 ▲ 131% vs 2023 (€ 47,657) Favourable step	€ 108,114 Profit after taxes 2025: € 108,114 ▼ 2% vs 2024 (€ 110,196) Unfavourable step	▼ 2%
Equity	€ 120,593 Equity 2022: € 120,593 First fiscal year in the series	€ 166,590 Equity 2023: € 166,590 ▲ 38% vs 2022 (€ 120,593) Favourable step	€ 276,786 Equity 2024: € 276,786 ▲ 66% vs 2023 (€ 166,590) Favourable step	€ 2,000 Equity 2025: € 2,000 ▼ 99% vs 2024 (€ 276,786) Unfavourable step	▼ 99%
Total debts	€ 48,841 Total debts 2022: € 48,841 First fiscal year in the series	€ 37,367 Total debts 2023: € 37,367 ▼ 23% vs 2022 (€ 48,841) Favourable step	€ 24,755 Total debts 2024: € 24,755 ▼ 34% vs 2023 (€ 37,367) Favourable step	€ 120,512 Total debts 2025: € 120,512 ▲ € 95,757 vs 2024 (€ 24,755) Unfavourable step	▲ € 95,757
Cash	€ 111,280 Cash 2022: € 111,280 First fiscal year in the series	€ 128,220 Cash 2023: € 128,220 ▲ 15% vs 2022 (€ 111,280) Favourable step	€ 178,192 Cash 2024: € 178,192 ▲ 39% vs 2023 (€ 128,220) Favourable step	€ 64,570 Cash 2025: € 64,570 ▼ 64% vs 2024 (€ 178,192) Unfavourable step	▼ 64%
Retained profit	€ 118,593 Retained profit 2022: € 118,593 First fiscal year in the series	€ 164,590 Retained profit 2023: € 164,590 ▲ 39% vs 2022 (€ 118,593) Favourable step	€ 274,786 Retained profit 2024: € 274,786 ▲ 67% vs 2023 (€ 164,590) Favourable step	€ 0 Retained profit 2025: € 0 ▼ 100% vs 2024 (€ 274,786) Unfavourable step	▼ 100%
Dividend	€ 1,600 Dividend 2022: € 1,600 First fiscal year in the series	€ 1,660 Dividend 2023: € 1,660 ▲ 4% vs 2022 (€ 1,600) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 1,660) Unchanged	€ 382,900 Dividend 2025: € 382,900 Unchanged (€ 0) Unchanged
Bank debt	€ 30,456 Bank debt 2022: € 30,456 First fiscal year in the series	€ 25,586 Bank debt 2023: € 25,586 ▼ 16% vs 2022 (€ 30,456) Favourable step	€ 15,766 Bank debt 2024: € 15,766 ▼ 38% vs 2023 (€ 25,586) Favourable step	€ 0 Bank debt 2025: € 0 ▼ 100% vs 2024 (€ 15,766) Favourable step	▼ 100%
Balance sheet total	€ 169,434 Balance sheet total 2022: € 169,434 First fiscal year in the series	€ 203,957 Balance sheet total 2023: € 203,957 ▲ 20% vs 2022 (€ 169,434) Unchanged	€ 301,541 Balance sheet total 2024: € 301,541 ▲ 48% vs 2023 (€ 203,957) Unchanged	€ 122,512 Balance sheet total 2025: € 122,512 ▼ 59% vs 2024 (€ 301,541) Unchanged	▼ 59%

Key figures of DR. VERCRUYSSE L. – DR. DE BROUWER M., fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. VERCRUYSSE L. – DR. DE BROUWER M.?

What happened at DR. VERCRUYSSE L. – DR. DE BROUWER M. in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Feb 12, 2026 New annual accounts for financial year 2025: profit of € 108,114 (▼ 2% vs 2024). Source: NBB ↗
Jun 24, 2021 New establishment in Gent. KBO
Jun 24, 2021 Start of the company according to the CBE. KBO

In short

From € 120,193 profit in 2022 to € 108,114 profit in 2025.

Paid € 107,748 in corporate taxes since 2022.

Best year ever: 2022, with € 120,193 profit.

Paid out € 386,160 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. VERCRUYSSE L. – DR. DE BROUWER M.? We notify you, reason included.

Follow DR. VERCRUYSSE L. – DR. DE BROUWER M.

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Loes Vercruysse Mathias De Brouwer

HUISARTSEN KEIZERPOORT

DR. VERCRUYSSE L. – DR. DE BROUWER M.

HUISARTSEN LEDEBERGPLEIN

Behind DR. VERCRUYSSE L. – DR. DE BROUWER M. are Loes Vercruysse and Mathias De Brouwer. Loes Vercruysse is also behind HUISARTSEN KEIZERPOORT. Mathias De Brouwer is also behind HUISARTSEN LEDEBERGPLEIN.

See the full network in the app

Directors

According to the 2025 annual accounts

Loes Vercruysse

Director

Also active at: HUISARTSEN KEIZERPOORT

Mathias De Brouwer

Director

Also active at: HUISARTSEN LEDEBERGPLEIN

Establishments

Establishment units

Physical locations of this company

Registered office

Stropstraat 147

9000 Gent

2.320.238.515

Lentestraat 39

9000 Gent

Active since 24 June 2021

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0770.301.447
VAT number: BE 0770.301.447
Registered office: Stropstraat 147, 9000 Gent
Names & denominations: DR. VERCRUYSSE L. – DR. DE BROUWER M.
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 24 June 2021
Peppol: Active · Active since 3 Nov 2025
Activities · NACE: Activiteiten van huisartspraktijken

View on CBE Public ↗ Annual accounts (NBB) ↗